LAYN has been defined as a Treg‐specific signature gene142 that is highly and specifically expressed in tumor‐infiltrating Tregs and correlates with poor prognosis in both NSCLC and CRCs patients.30 The gene discussed is LAYN; the disease is neoplasm.